Key Insights

Highlights

Success Rate

84% trial completion

Published Results

26 trials with published results (15%)

Research Maturity

76 completed trials (44% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

8.8%

15 terminated out of 171 trials

Success Rate

83.5%

-3.0% vs benchmark

Late-Stage Pipeline

13%

23 trials in Phase 3/4

Results Transparency

34%

26 of 76 completed with results

Key Signals

26 with results84% success15 terminated

Data Visualizations

Phase Distribution

123Total
Not Applicable (51)
Early P 1 (4)
P 1 (15)
P 2 (30)
P 3 (18)
P 4 (5)

Trial Status

Completed76
Unknown28
Recruiting21
Terminated15
Not Yet Recruiting11
Active Not Recruiting10

Trial Success Rate

83.5%

Benchmark: 86.5%

Based on 76 completed trials

Clinical Trials (171)

Showing 20 of 20 trials
NCT07733193Phase 3Not Yet RecruitingPrimary

Impact of Prophylactic Bone Radiation Therapy in Patients With Bone Metastases.

NCT07391410RecruitingPrimary

Registry for Bone Metastases

NCT03261544Recruiting

Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?

NCT07687225Not ApplicableNot Yet Recruiting

Surgery vs. No Surgery for Primary Tumor in De Novo Stage IV Breast Cancer With Solitary Bone Metastases

NCT04157166Not ApplicableCompletedPrimary

Evaluation of an Accelerated Body-whole Bone CT Procedure With the CZT(Cadmium-Zinc-Telluride) "VERITON-CT ™" Camera

NCT02810262CompletedPrimary

Association of Bone and Metabolic Parameters With Overall Survival in Patients With Bone Metastases From Adenocarcinoma Lung Cancer (POUMOS)

NCT06918860RecruitingPrimary

Analysis of Intramedullary Nail and Prosthetic Reconstruction After Surgical Treatment of Bone Metastases of Proximal Femur

NCT05495802WithdrawnPrimary

Regional Database for Collecting Clinical-biological and Imaging Data "Secondary Bone Oncology and Bone Localizations of Hematologic Diseases"

NCT06189079RecruitingPrimary

Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study

NCT03823534Phase 3RecruitingPrimary

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

NCT07540650Phase 2Not Yet RecruitingPrimary

Prophylactic Radiotherapy to Prevent Bone Complications in Patients With Metastatic Solid Cancers

NCT07537972Phase 2Not Yet Recruiting

Denosumab Strategy for Liver Cancer With Bone Metastases

NCT06470503Not ApplicableEnrolling By InvitationPrimary

EXercise Enhancement After RadioTherapy for Bone Metastases

NCT03869762Phase 2Terminated

Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases.

NCT03795207Phase 2Active Not Recruiting

Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)

NCT02356497RecruitingPrimary

Prospective Evaluation of Interventional Studies on Bone Metastases - the PRESENT Cohort

NCT04307914Not ApplicableActive Not RecruitingPrimary

Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases

NCT07429422Not ApplicableRecruiting

SBRT Technique Implementation for Spinal Metastases Irradiation

NCT00699751Phase 3Completed

A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases

NCT02226276Not ApplicableActive Not RecruitingPrimary

Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer

Scroll to load more

Research Network

Activity Timeline